118 related articles for article (PubMed ID: 10863475)
1. Histochemistry of Ki-67 antigen in ameloblastomas.
Nagao Y; Wato M; Tanaka A
J Osaka Dent Univ; 1999 Oct; 33(2):53-7. PubMed ID: 10863475
[TBL] [Abstract][Full Text] [Related]
2. Cystic ameloblastoma--behavior and treatment of 21 cases.
Rosenstein T; Pogrel MA; Smith RA; Regezi JA
J Oral Maxillofac Surg; 2001 Nov; 59(11):1311-6; discussion 1316-8. PubMed ID: 11688034
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
Han B; Li L; Wang H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma.
Maya R; Sekar B; Murali S
Indian J Dent Res; 2012; 23(1):15-9. PubMed ID: 22842243
[TBL] [Abstract][Full Text] [Related]
6. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma.
Li TJ; Browne RM; Matthews JB
Histopathology; 1995 Mar; 26(3):219-28. PubMed ID: 7797199
[TBL] [Abstract][Full Text] [Related]
7. [Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma].
Liu J; Wang S; Chen X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):62-4. PubMed ID: 11955366
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
Meer S; Galpin JS; Altini M; Coleman H; Ali H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.
Rizzardi C; Leocata P; Ventura L; Zweyer M; Brollo A; Schneider M; Melato M
Anticancer Res; 2009 Apr; 29(4):1137-42. PubMed ID: 19414356
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of alpha 1-antitrypsin, alpha 1-antichymotrypsin, transferrin and ferritin in ameloblastoma.
Takahashi H; Tsuda N; Yamabe S; Fujita S; Okabe H
Anal Cell Pathol; 1995 Sep; 9(2):135-50. PubMed ID: 7492517
[TBL] [Abstract][Full Text] [Related]
12. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
[TBL] [Abstract][Full Text] [Related]
13. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
14. A immunohistochemical study of the peripheral ameloblastoma.
Kishino M; Murakami S; Yuki M; Iida S; Ogawa Y; Kogo M; Toyosawa S
Oral Dis; 2007 Nov; 13(6):575-80. PubMed ID: 17944675
[TBL] [Abstract][Full Text] [Related]
15. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
[TBL] [Abstract][Full Text] [Related]
16. P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas.
Florescu A; Simionescu C; Ciurea R; Pitru A
Rom J Morphol Embryol; 2012; 53(1):105-9. PubMed ID: 22395508
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya.
Ong'uti MN; Cruchley AT; Howells GL; Williams DM
Int J Oral Maxillofac Surg; 1997 Oct; 26(5):376-9. PubMed ID: 9327291
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts.
Piattelli A; Lezzi G; Fioroni M; Santinelli A; Rubini C
J Endod; 2002 Feb; 28(2):55-8. PubMed ID: 11833688
[TBL] [Abstract][Full Text] [Related]
20. Different antigen unmasking techniques lead to significant differences in immunohistochemical staining of Ki-67 (Mib-1) in renal cell carcinomas.
Heuschmid M; Hofmockel G; Dexler B; Dämmrich J; Bassukas ID
Oncol Rep; 2002; 9(1):19-22. PubMed ID: 11748449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
